Search
Search Results
##search.searchResults.foundPlural##
-
PATHOGENESIS OF MALARIA IN TISSUES AND BLOOD
4547PDF: 1938HTML: 17803 -
PATHOGENESIS AND TREATMENT OF THROMBOHEMORRHAGIC DIATHESIS IN ACUTE PROMYELOCYTIC LEUKEMIA
1836PDF: 823HTML: 10240Figures 1,2,3: 188 -
THE ROLE OF INFECTION IN THE PATHOGENESIS OF VASO-OCCLUSIVE CRISIS IN PATIENTS WITH SICKLE CELL DISEASE.
5188PDF: 1333HTML: 2755Cover letter: 200 -
-
VON WILLEBRAND FACTOR, ANGIODYSPLASIA AND ANGIOGENESIS
3772PDF: 1594HTML: 8047Randi Fig: 187 -
CLONAL HEMATOPOIESIS: ROLE IN HEMATOLOGIC NON-HEMATOLOGIC MALIGNANCIES CLONAL HEMATOPOIESIS AND MALIGNANCIES
3051PDF: 915HTML: 2021 -
HIV-ASSOCIATED VENOUS THROMBOEMBOLISM
3936PDF: 1490HTML: 8518 -
NEW THERAPEUTIC OPTIONS FOR THE TREATMENT OF SICKLE CELL DISEASE Guest Editor: Raffaella Origa
6892PDF: 3663HTML: 773 -
ELEVATED P-SELECTIN IN SEVERE COVID-19: CONSIDERATIONS FOR THERAPEUTIC OPTIONS P-Selectine and COVID-19
1895PDF: 706HTML: 238 -
Acute Cytomegalovirus infection as a cause of venous thromboembolism
1585PDF: 851HTML: 1039Picture 1: 172 -
SICKLE CELL DISEASE AND VENOUS THROMBOEMBOLISM
2272PDF: 897HTML: 2099 -
High Prevalence of Antiphospholipid Antibodies in Children with Non-Transfusion Dependent Thalassemia and Possible Correlations with Microparticles Antiphospholipid Antibodies and Thalassemia in children
951PDF: 611HTML: 290 -
THE PROTHROMBOTIC STATE ASSOCIATED WITH SARS-COV-2 INFECTION: PATHOPHYSIOLOGICAL ASPECTS COVID and Thrombosis
2000PDF: 820HTML: 225 -
TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity
2282PDF: 1629HTML: 274 -
FAMILIAL MEDITERRANEAN FEVER AND HYPERCOAGULABILITY
1227PDF: 714HTML: 1242 -
SARS-CoV-2 INFECTED PATIENTS: FROM A HEMATOLOGIST PERSPECTIVE COVID-19 and Hematology
1088PDF: 967HTML: 337 -
PERIOPERATIVE MANAGEMENT OF SICKLE CELL DISEASE: A NARRATIVE REVIEW
8512PDF: 3259HTML: 1249 -
PLASMODIUM VIVAX INFECTIONS IN DUFFY-NEGATIVE INDIVIDUALS: A PARADIGM SHIFT IN INDIAN MALARIA EPIDEMIOLOGY Duffy negative malaria in India
1244PDF: 847HTML: 78 -
Monocyte HLA-Dr Expression to Monitor Immune Response and Potential Infection Risks Following Vaso-Occlusive Crises in Patients with Sickle Cell Anemia Monocyte HLA-DR expression in SCA patients
710PDF: 549HTML: 219 -
PLASMACELL NEOPLASMS WITH SPREADING IN THE BLOOD AND TISSUES: EXTRAMEDULLARY MYELOMA DISEASE A RARE AGGRESSIVE FORM OF MULTIPLE MYELOMA (First of two parts) Extra Medullary Myeloma
2486HTML: 281PDF: 887 -
FDG-PET SCAN: A NEW PARADIGM FOR FOLLICULAR LYMPHOMA MANAGEMENT.
3329PDF: 1249HTML: 2208 -
ENDOTHELIAL BIOMARKERS IN PATIENTS RECOVERED FROM COVID-19 ONE YEAR AFTER HOSPITAL DISCHARGE: A CROSS-SECTIONAL STUDY Endothelial biomarkers in COVID-19 recoverers one year after hospital discharge.
1308PDF: 733HTML: 330 -
Microangiopathic Anemia of Acute Brucellosis – is it a True TTP?
1199PDF: 796HTML: 1776 -
DISTRIBUTION OF DNA DAMAGE REPAIR GENE POLYMORPHISM hOGG1, XRCC1 and p53 AMONG SICKLE CELL DISEASE PATIENTS IN INDIA
1566PDF: 792HTML: 1488Table Genotype and allele frequencies of hOGG1 codon 326 Ser>Cys and p53 72Arg>Pro polymorphisms among SCD patients and control group: 183







